Amgen first-quarter profit dips 1%, revenue rises 22%
Related Articles
-
Amgen first-quarter profit dips 1%, revenue rises 22%
(Reuters) -Amgen reported a slightly lower first-quarter profit on Thursday, citing higher operating and interest expense from its recent acquisition of rare disease drugmaker Horizon Therapeutics, partially offset by double-digit revenue growth. The biotechnology company's adjusted profit fell 1% to $3.96 per share, which still beat the average analyst estimate of $3.88 per share, according to LSEG data. The results were "essentially in-linish although not anything significant for the Street...
-
Robinhood swings to profit from year-ago loss
The company reported a profit of $157 million or 18 cents per share for the three months ended March 31, compared with a loss of $511 million or 57 cents per share a year ago. Policy tightening by the Federal Reserve has allowed companies to increase earnings from their cash deposits and their portfolio of bond investments. Brokers like Robinhood, which offers traders the ability to borrow against their investments, can now charge higher interest rates on these loans.
-
Ferrari profit rises but investors cool on mixed outlook
Profit at Ferrari rose by nearly a fifth in the first quarter, driven by increasing demand for bespoke personalisations.